- Home
- MRVI vs BGR Comparison
MRVI vs BGR Comparison
Compare MRVI & BGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- BGR
- Stock Information
- Founded
- MRVI 2014
- BGR 2004
- Country
- MRVI United States
- BGR United States
- Employees
- MRVI N/A
- BGR N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- BGR Trusts Except Educational Religious and Charitable
- Sector
- MRVI Health Care
- BGR Finance
- Exchange
- MRVI Nasdaq
- BGR Nasdaq
- Market Cap
- MRVI 312.4M
- BGR 321.9M
- IPO Year
- MRVI 2020
- BGR N/A
- Fundamental
- Price
- MRVI $2.22
- BGR $12.69
- Analyst Decision
- MRVI Hold
- BGR
- Analyst Count
- MRVI 10
- BGR 0
- Target Price
- MRVI $6.84
- BGR N/A
- AVG Volume (30 Days)
- MRVI 1.9M
- BGR 73.3K
- Earning Date
- MRVI 05-12-2025
- BGR 01-01-0001
- Dividend Yield
- MRVI N/A
- BGR 6.02%
- EPS Growth
- MRVI N/A
- BGR N/A
- EPS
- MRVI N/A
- BGR 0.69
- Revenue
- MRVI $241,856,000.00
- BGR N/A
- Revenue This Year
- MRVI N/A
- BGR N/A
- Revenue Next Year
- MRVI $10.73
- BGR N/A
- P/E Ratio
- MRVI N/A
- BGR $18.97
- Revenue Growth
- MRVI N/A
- BGR N/A
- 52 Week Low
- MRVI $1.67
- BGR $11.38
- 52 Week High
- MRVI $10.03
- BGR $13.37
- Technical
- Relative Strength Index (RSI)
- MRVI 52.01
- BGR 57.17
- Support Level
- MRVI $2.20
- BGR $12.12
- Resistance Level
- MRVI $2.41
- BGR $12.69
- Average True Range (ATR)
- MRVI 0.15
- BGR 0.18
- MACD
- MRVI 0.01
- BGR 0.02
- Stochastic Oscillator
- MRVI 58.06
- BGR 77.40
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.